Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).

In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, multicenter, randomized controlled study, was started in survivors of sudden cardiac death resulting from documented ventricular tachyarrhythmias. Through December 1991, 230 survivors (46 women, 184 men; mean age 57 +/- 11 years) of cardiac arrest caused by ventricular tachyarrhythmias were randomly assigned to receive either oral propafenone (56 patients), amiodarone (56 patients), or metoprolol (59 patients) or to have an implantable defibrillator (59 patients) without concomitant antiarrhythmic drugs. The primary endpoint of the study was total mortality. In March 1992, the propafenone arm of CASH was stopped because of excess mortality compared with the implantable defibrillator group. This article presents preliminary results of the comparison of implantable defibrillator therapy with propafenone therapy. A significantly higher incidence of total mortality, sudden death (12%), and cardiac arrest recurrence or sudden death (23%) was found in the propafenone group compared with the implantable defibrillator-treated patients (0%, p < 0.05). It was concluded that, in survivors of cardiac arrest, propafenone treatment is less effective than implantable defibrillator treatment.

[1]  G. Lamas,et al.  Left ventricular thrombus formation after first anterior wall acute myocardial infarction. , 1988, The American journal of cardiology.

[2]  R. Winkle,et al.  Long-term outcome with the automatic implantable cardioverter-defibrillator. , 1989, Journal of the American College of Cardiology.

[3]  M. Josephson,et al.  Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing. , 1983, The American journal of cardiology.

[4]  P. Kudenchuk,et al.  Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. , 1990, Journal of the American College of Cardiology.

[5]  J. Ruskin,et al.  Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. , 1988, The New England journal of medicine.

[6]  H A Fozzard,et al.  Electromechanical dissociation and its possible role in sudden cardiac death. , 1985, Journal of the American College of Cardiology.

[7]  J. Mason A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. , 1993, The New England journal of medicine.

[8]  Robert Lemery,et al.  Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.

[9]  J. Mason,et al.  Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest. , 1988, The American journal of cardiology.

[10]  F. Morady,et al.  Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. , 1983, The American journal of cardiology.

[11]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[12]  R. Gillum,et al.  Sudden coronary death in the United States: 1980-1985. , 1989, Circulation.

[13]  M. Josephson,et al.  Cardiac arrest recorded on ambulatory electrocardiograms. , 1984, The American journal of cardiology.

[14]  J. Ruskin,et al.  Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. , 1980, The New England journal of medicine.

[15]  E. Rapaport,et al.  Sudden cardiac death. , 1988, The American journal of cardiology.

[16]  R. Winkle,et al.  Determinants of survival in patients with ventricular tachyarrhythmias. , 1983, The New England journal of medicine.

[17]  Jeffrey L. Anderson,et al.  The ESVEM Trial: Electrophysiologic Study Versus Electrocardiographic Monitoring for Selection of Antiarrhythmic Therapy of Ventricular Tachyarrhythmias , 1989, Circulation.

[18]  W. Kannel,et al.  Sudden death: lessons from subsets in population studies. , 1985, Journal of the American College of Cardiology.